Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-25 @ 5:39 PM
Study NCT ID:
NCT01414959
Status:
COMPLETED
Last Update Posted:
2017-08-29
First Post:
2011-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Sponsor:
Medical University of Vienna
Organization:
Study Overview
Official Title:
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.
Detailed Description:
Methods: microdialysis, blood sampling, bronchoalveolar lavage
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: